Early Outcomes of Faricimab Treatment for Diabetic Macular Edema in Patients Previously Treated With Anti-VEGF Therapy
Faricimab appears to be a viable option for some DME patients who require a change in anti-VEGF therapy. <b>[<i>Ophthalmic Surg Lasers Imaging Retina</i> 2025;56:408-414.]</b>.
Authors
- Sumit Sharma (ORCID: https://orcid.org/0000-0001-5769-0717)
- Danny A. Mammo (ORCID: https://orcid.org/0000-0002-7496-5118)
- Peter K. Kaiser (ORCID: https://orcid.org/0000-0001-5126-045X)
- Alex Yuan (ORCID: https://orcid.org/0000-0003-0191-8035)
- Andrei-Alexandru Szigiato (ORCID: https://orcid.org/0000-0003-0862-9068)
- Amy Babiuch (ORCID: https://orcid.org/0000-0002-0782-2694)
- Nitesh Mohan (ORCID: https://orcid.org/0000-0001-6929-9504)
- Aleksandra Rachitskaya (ORCID: https://orcid.org/0000-0001-5545-9474)
- Sunil K. Srivastava (ORCID: https://orcid.org/0000-0002-0398-8806)
- Justis P. Ehlers (ORCID: https://orcid.org/0000-0001-6763-7768)
- Katherine E. Talcott (ORCID: https://orcid.org/0000-0003-0458-4181)
Institutions
- Cleveland Eye Clinic (US)
Publication Details
- Journal
- Ophthalmic surgery, lasers & imaging retina
- Published
- 2025-04-21
- DOI
- https://doi.org/10.3928/23258160-20250228-01
- Citations
- 1
- Primary Topic
- Retinal Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.71